Found: 9
Select item for more details and to access through your institution.
Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression.
- Published in:
- Asian Journal of Andrology, 2022, v. 24, n. 6, p. 684, doi. 10.4103/aja202285
- By:
- Publication type:
- Article
TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression.
- Published in:
- Asian Journal of Andrology, 2021, v. 23, n. 2, p. 188, doi. 10.4103/aja.aja_60_20
- By:
- Publication type:
- Article
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 14, p. 6195, doi. 10.1002/cam4.2399
- By:
- Publication type:
- Article
Efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine in Chinese women aged 18-25 years: event-triggered analysis of a randomized controlled trial.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 12, doi. 10.1002/cam4.869
- By:
- Publication type:
- Article
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.
- Published in:
- SCIENCE CHINA Life Sciences, 2020, v. 63, n. 4, p. 582, doi. 10.1007/s11427-019-9547-7
- By:
- Publication type:
- Article
Comparative study of the cervista and hybrid capture 2 methods in detecting high-risk human papillomavirus in cervical lesions.
- Published in:
- Diagnostic Cytopathology, 2014, v. 42, n. 3, p. 213, doi. 10.1002/dc.23025
- By:
- Publication type:
- Article
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomized controlled trial.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 11, p. 2612, doi. 10.1002/ijc.28897
- By:
- Publication type:
- Article
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 11, p. 2604, doi. 10.1002/ijc.28896
- By:
- Publication type:
- Article